Mahzi aims to unite patient and family groups, academic researchers, other industry members, and our internal team of experts to develop therapies for patients with under-diagnosed and under-served rare genetic neurodevelopmental disorders. Our team is experienced in all aspects of biopharmaceutical research, development, and manufacturing and is driven to make a difference in the lives of patients with rare genetic diseases.